Corpus ID: 37311023

Atazanavir (Reyataz).

@article{Reyataz2003Atazanavir,
  title={Atazanavir (Reyataz).},
  author={Atazanavir Reyataz},
  journal={Project Inform perspective},
  year={2003},
  volume={36},
  pages={
          7-10
        }
}
Atazanavir (Reyataz) is a protease inhibitor that received FDA approval in June 2003. Other approved drugs in this class include amprenavir, indinavir, Kaletra (ritonavir + lopinavir), nelfinavir, ritonavir and saquinavir. 
1 Citations